Seritage Growth Properties (SRG) Form 8-K — Aug 14, 2026

$SRGForm 8-KItems 2.02, 9.01Filed Aug 14, 2026, 4:28 PM ET0001193125-26-352377Original filing

Seritage Growth Properties reported a Q2 2026 net loss attributable to common shareholders of $7.4 million, or $0.13 per share, a sharp improvement from the $29.7 million ($0.53 per share) loss in Q2 2025. The company recorded no new impairments in the quarter, after booking $15.2 million of consolidated property impairments and $5.2 million of other-than-temporary impairments on unconsolidated entities during the first half of 2026. On July 24, 2026, the company closed a refinancing: a new $15.0 million term loan facility plus a $25.0 million revolver, with $15.0 million drawn at closing, used together with cash to fully repay the $50.0 million prior term loan balance.

Key figures

Eps: -$0.13 (Q2 2026 net loss per Class A common share); -$0.69 for the six months
Revenue: $1.874 million (Q2 2026 total revenue; $3.924 million for the six months ended June 30, 2026)
Net Income: -$7.353 million (Q2 2026 net loss attributable to common shareholders); -$38.896 million for the six months
Total Debt: $49.660 million term loan facility (net) as of June 30, 2026; refinanced July 24, 2026 with a $15.0 million term loan plus $15.0 million drawn on a $25.0 million revolver
Revenue Yoy: -59.7% derived from stated Q2 total revenue of $1.874M vs $4.653M in Q2 2025
Total Assets: $353.579 million as of June 30, 2026
Cash Position: $62.9 million as of June 30, 2026 (including $14.4 million restricted); $48.6 million as of August 14, 2026 (including $32.7 million restricted)
Shares Outstanding: 56324607
New revolver facility: $25.0 million ($15.0 million drawn; $10.0 million available)
New term loan facility: $15.0 million
Portfolio at june 30 2026: 9 properties; ~0.8 million SF GLA and 139 acres (4 consolidated, 5 unconsolidated)
Post quarter sale proceeds: $3.0 million
H1 2026 preferred dividends: $2.45 million
H1 2026 unconsolidated otti: $5.2 million
Q2 gross asset sale proceeds: $11.0 million
Repaid prior term loan balance: $50.0 million
Dallas psa initial option payment: $169,200
Dallas psa anticipated gross proceeds: $50.8 million
Series a preferred dividend per share: $0.43750 (quarterly, declared Feb/Apr/Jul 2026)
H1 2026 consolidated property impairment: $15.2 million
Post quarter unconsolidated distribution: $8.9 million
Series a preferred liquidation preference: $70.0 million
H1 2026 unconsolidated distributions received: $8.8 million
Dallas psa monthly option payment through dec 2026: $126,900
Dallas psa monthly option payment jan 2027 to jan 2028: $274,950

Price after filing

1 day: 0.0%7 days: -6.2%30 days: -15.4%

Close on the filing date to close N calendar days later (from $2.27). Historical, not a forecast.

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.